1821 In the series of patients treated at our institution, the recurrence and mortality rates were 75% and 83%, respectively, which are significantly higher than the corresponding rates within the cohort retrieved from the literature (40% and 22%, respectively)
Surgery may involve: Arthroscopic debridement (cleaning up damaged tissue) Repair of the TFCC using sutures Ulnar shortening procedures if bone length contributes to tearing Post-surgical recovery still requires structured physiotherapy to regain strength, mobility, and function
doi:10.1017/S0007114515002950 Egert S, Bosy-Westphal A, Seiberl J, et al
Product name: Tirzepatide Declared content: 20 mg per pen Declared volume: 3 ml Form: Aqueous solution Receptor profile: GLP-1 and GIP Grade: Research use only Packaging: Pen Additional notes Important notice: This material is intended exclusively for controlled laboratory, analytical and scientific research